Flotek Industries, Inc. (FTK) Earnings Call Transcript & Summary
May 8, 2024
Earnings Call Speaker Segments
Michael Critelli
executiveThanks so much, and welcome everyone. We're glad you could join us for Flotek's conference call covering earnings for the first quarter of 2024. With me today are Ryan Ezell, our Chief Executive Officer, and Bond Clement, our Chief Financial Officer. To start, we'll share some prepared comments about how our business performed and what our financials looked like during Q1 2024, plus our outlook for the entire 2024 year. After those remarks, we'll take any questions you might have. Yesterday afternoon, we released Flotek's press release covering financial and operating results for the first quarter of 2024. An updated Q1 earnings presentation was also posted, and we'll refer to it during today's call. You can find both of these in the Investor Relations area of our website. Beyond that, this call is being webcast, and once we finish, a replay will be accessible on our site. Please keep in mind that anything said today about projections or expectations for future events counts as forward-looking statements. Such statements carry a variety of risks and uncertainties, and many of those are outside our control. These risks and uncertainties might lead actual results to differ materially from what we currently expect; we encourage listeners to look over our earnings release and the risk factors described in our SEC filings. Also, please check the reconciliations included in the earnings press release and corporate presentation, since management will talk about non-GAAP metrics during this call. With all that said, I'll hand things over to Ryan Ezell, our CEO.
Ryan Ezell
executiveAppreciate that, Mike, and hello everyone. We're glad you're taking an interest in Flotek and joining us today while we walk through how operations and finances came out in the first quarter of 2024. My feelings about our Q1 2024 performance are positive, and I'm even more enthusiastic about what this year still holds. Without a doubt, 2023 served as a period of reinvention for this organization, yet 2024 will signal the beginning of a renewed Flotek — one demonstrating steady profitability and rising shareholder value as we accelerate toward a fresh chapter built on distinctive chemistry and data analytic solutions. When it comes to providing strategic answers to numerous of the hardest challenges our industry faces, no other company is positioned better. No matter if we're talking about operators tackling tough completion issues such as rising water output and lower BOE, pumping companies trying to set themselves apart by getting the most out of utilization, or oil and gas operators hurrying to meet the new EPA flare rules using their distinctive real-time measurement technologies — there has never been a more thrilling moment to be part of Flotek. Keeping that in mind, I want to move to Slide 7 and go over our main highlights for the quarter, which Bob will cover thoroughly shortly. We posted large gains compared with a year earlier in gross profit, adjusted gross profit and adjusted EBITDA. That gave us net income for a third quarter in a row, and it marked the 11th straight period in which adjusted EBITDA as a percentage of revenue improved. It's worth pointing out that adjusted EBITDA for Q1 2024 came in higher than the figure for all of 2023 combined. Gross profit margin came to 22%, while adjusted gross profit margin was 25%. External chemistry sales in 2024 were the strongest we've seen in a first quarter since this turnaround began more than 3 years ago, rising 27% versus the prior year. Sequentially they declined, but that mirrors what happened in the opening quarter of each of the past 3 years, since average fleet counts also fell from one quarter to the next. Revenue for our data analytics division rose $0.08 compared with the prior quarter, partly because of ongoing gains in service-related data revenue. Beyond that improvement, we're continuing field testing on the new Cal-X spectrometer, and a midyear 2024 launch remains on schedule. Equally important, every one of these results came while operations recorded 0 recordable and lost time incidents, which pushes Flotek's active run to more than 843 days with no recordable incident. At this point I want to recognize each and every employee for their dedication to safety and service quality in delivering these remarkable outcomes. I'm anticipating that we'll keep carrying this momentum forward all through 2024. Turning to the quarter with a closer look, our revenue dipped a bit on a sequential basis. That decline largely comes from fewer external chemistry sales compared with Q4 2023. This pattern of seasonality has shown up consistently ever since the company kicked off its strategic turnaround more than 3 years ago. Zooming in on Slide 9: external chemistry revenues for Q1 2024 climbed 27% compared with Q1 of 2023. Over these last 3 years, Q1 revenue from our external chemistry sales reached its peak, despite average frac fleet counts across North America land falling to their lowest level during that same period. That indicates we're gaining share in the market as every annual round of fleet count stabilization unfolds, which comes from carrying out our corporate strategy—one that treats chemistry as the common platform for value creation. More and more customers are embracing our prescriptive chemistry management business model, even though it relies on our customized engineering method together with our patented complex NanoFlu technologies to generate wells that outperform competitor wells nearby. Flotek will remain at the forefront of innovation and multidisciplinary progress as we bring new technologies to market, including AI-driven reservoir modeling, in order to address the impacts of water inhibition, encourage preferential microfluidic behavior within nanopore environments, and increase ultimate recovery of hydrocarbons from every asset. For the second quarter, we're expecting a big jump in sales of chemistry to outside customers, and we also expect growth for all of 2024 in external chemistry. On that note, sales of chemistry to external customers in April alone have already hit more than 70% of the total we brought in during the entire first quarter of 2024; our ProFrac-related revenue grew 19% from the prior period. The chemistry volumes spelled out in the long-term supply agreement with ProFrac were structured to smooth out market swings and give Flotek some protection as it works to keep economies of scale and stay operationally stable. Our collaboration keeps developing into something genuinely transformative for E&P operators when it comes to efficiency and how the reservoir performs overall. Revenue for our data analytics business was up 18% versus the fourth quarter of 2023. As we keep shifting toward a Data as a Service approach and roll out the next-generation JP3 measurement system, we're opening up meaningful opportunities in the upstream market, and the company anticipates 50% growth for the data analytics business in 2024. Looking more broadly, oil and gas demand should keep rising over the coming decade, with even more needed through 2045. To sustain production and deliver the extra supply that's required, long-term investment across both short and long barrel cycles will be essential; and even with commodity prices swinging in the near term, the fundamentals for energy-related services stay solid. Over the next several years, electricity needs in the United States are going to rise by more than 15% by 2030 — something we haven't seen in close to twenty years — and natural gas currently covers more than 40% of that demand. As the world economy keeps growing overall, it will drive considerable need for every kind of energy, and that in turn will make service intensity greater in our industry. Turning to what's left of 2024, we're keeping our attention sharply fixed on growing revenue, gaining market share, achieving cost efficiencies, and delivering returns for shareholders, since we're strongly positioned to seize opportunities both at home and abroad. Our growing range of services gives us confidence that we can deliver distinctive, best-in-class solutions that maximize value across our customers' value chain. At this point, I'll hand things over to Bond, who will walk us through the main financial points.
J. Clement
executiveThanks, Ryan. Morning, everyone. In Q1 2024, we turned in a solid performance, despite oil services demand being somewhat weak because of completions tied to natural gas. Seasonality and lower frac fleet activity cut into revenue, yet margins still grew, and we continued our streak of improved financial outcomes, capping it with another quarter of strong adjusted EBITDA. Now I'd like to go over several important financial points from the first quarter of 2024. As I do, I'll reference slides from the presentation we put on our website yesterday. On Slide 7, you'll see what we achieved in the first quarter and the significant financial gains we produced. The key highlights for the quarter were growth compared to last year and net income of $11 million once noncash gains from Q1 2023 are excluded. There was a $6.9 million rise in gross profit, adjusted gross profit came in $7.4 million higher, and adjusted EBITDA saw a $7.9 million improvement. Turning to quarterly revenue, our total came to $40 million, a decrease from the same period a year ago. The drop stemmed from reduced related party activity tied to ProFrac, though this was partly offset by external chemistry customer revenue climbing 27%. As Ryan noted earlier and illustrated on Slide 9, each of the last 3 years has brought a first-quarter decline in external chemistry revenues. Given where we see things heading and how well April has begun, a notable rise in chemistry revenue from outside customers should occur in Q2. Keep in mind that during last year's second quarter, external chemistry revenue was up 68% relative to the trough we saw in Q1 of 2023. Turning to data analytics, that segment delivered robust growth, with JP3-related revenue climbing 18% quarter over quarter; we anticipate that data analytics revenue growth will be weighted toward the back half of 2024, consistent with when we expect our new analyzer to be commercially deployed. Let's go to Slide 10. For a fifth quarter in a row, gross profit went up in Q4. In Q1, gross profit rose by $7 million — an increase of almost 400% — versus only $1.9 million during the same stretch in 2023. One thing worth flagging: the supply agreement's minimum chemistry purchase requirements applied in Q1 2024, whereas they did not apply in Q1 2023, since measurement of those minimum purchase requirements started on June 1 of last year. Thanks to the extra revenue tied to our supply agreement requirements, along with our ongoing push on cost improvements, we were able to deliver strong margins for the quarter. Let me walk through a handful of concrete illustrations of how margins kept getting better in the first quarter. Freight expense measured against revenue came down by about 50% compared with the same period a year earlier. That resulted from many programs we carried out across the prior year, among them cutting back on dedicated trucking and making use of staging yards positioned strategically so that last mile deliveries and overall efficiency could improve. During that same prior year, we additionally achieved significant gains in the way materials are procured. Vendors were consolidated so that our spending power could be used to secure improved pricing along with rebates. Another area of emphasis has been purchasing direct, which removes expensive intermediary margin layers and lowers the biggest expenditure on our P&L. A quick word on SG&A. In the first quarter, SG&A fell to $6.1 million, an improvement of approximately 6% both versus the comparable quarter a year ago and on a sequential basis. Reduced personnel costs and professional fees drove that decrease. Turning to Slide 11. Adjusted EBITDA came in positive for a third quarter in a row, up $7.9 million from the first quarter a year ago. That marks the 11th straight quarter of adjusted EBITDA gains, a run extending back to the second quarter of 2021. On the bottom line, net income for the first quarter was $1.6 million, versus a net loss of $9.3 million in the first quarter of 2023 after adjusting for $31 million of noncash gains. Now a few points on the balance sheet. As of March 31, amounts drawn under our ABL stood at $3.1 million, which is $4.4 million less, or a 58% decrease, from what was outstanding at year-end. Consequently, debt to trailing 12-month adjusted EBITDA fell to 0.3x as of March 31. A brief comment on our 2024 guidance. Because of uncertainty surrounding when natural gas pricing will improve and how that will affect completion activity, we did not provide specific revenue guidance for 2024. That said, we're looking at Q1 as the softest top-line period we'll see all year, and for the whole of 2024, we think revenue will come in around the same level as last year. Because of the positive impact from all the expense cuts we've made, plus a full twelve months of measurement in 2024 related to the minimum chemistry purchase obligations, we expect margins to climb quite a bit versus 2023. Based on where our forecasts stand right now, adjusted gross profit margin for 2024 ought to fall somewhere between 18% and 22%, and that compares quite favorably with the 15% adjusted gross profit margin we posted in 2023. With margins expected to be higher, we anticipate 2024 adjusted EBITDA in a range of $10 million to $16 million, once again a major step up from 2023 adjusted EBITDA of only $1.5 million. To wrap up, Flotek keeps delivering strong, repeatable results with a focus on resilient profitability. Looking at how natural gas prices are trending right now, we expect more completions to get done as we head into the latter portion of the year. That said, if activity were to hold steady at the same level for the entire year, what we delivered in the first quarter shows how resilient we are, since we posted solid margins and growth on the bottom line during a period when activity was fairly light. With that, I'll hand things back to Ryan to wrap up.
Ryan Ezell
executiveThank you, Bond. If you'll move with me to Slide 19. Our enthusiasm for 2024 was very high, since we see enormous room to expand in both the chemistry side of our business and in Data Analytics, and we think Flotek, as of today, stands out as an appealing chance to invest. The results from our first quarter brought us profitability, and we remain set up to keep growing as the go-to collaborator for sustainable chemistry and data solutions. The strides we've taken make me proud, and I have full confidence in our capacity to deliver from here on. We're grateful for the ongoing backing of everyone with a stake in our company, and we hope you feel the same excitement we do about what lies ahead for Flotek, and we're eager to share news of more progress. Operator, please open the line for questions.
Jeff Grampp
analystI've got a question about JP3, and more specifically about the EPA regulatory approval that you're pursuing. Can you give us any update on where that timeline stands, or your best guess as of today? And then I'm curious what your thinking or expectations are regarding the adoption curve or the pace you'd anticipate from that, assuming you do secure the approval.
Ryan Ezell
executiveAt this point, we feel good about the progress we've made and the ongoing dialogue with the EPA. Tom and the team are performing incredibly well on that front. And as of now, we anticipate that EPA adoption will arrive alongside the regulations around the same time our production starts up by midyear; so I believe we're advancing nicely on both of those fronts; and what's been genuinely thrilling is that we keep witnessing enormous uptake of our Data as a Service as a share of revenue. Going back to Q1 of '23, Data as a Service accounted for roughly 23% of our revenue; by Q1 of '24, that figure had reached nearly 50%. So there are substantial opportunities in that area. And I think as our Cal-X model, which is our new Gen 3 measurement unit, enters production fully, seen by the middle of the year. I believe our position with the regulatory body, the EPA, will align right with that; and it ought to provide us with a lift in the back half of the year.
Jeff Grampp
analystThat's great, sounds good, and thanks for that. Moving to my follow-up, I'd like to dig deeper into how you're deploying capital. Your debt load is modest, the model doesn't require heavy capital, and it's clear you're becoming a business that produces substantial EBITDA and cash. What's your thinking on plowing that potential back into operations, looking at M&A, or pursuing any other possibilities that could be available?
Ryan Ezell
executiveThere are a few things underway: since I joined, this is the first time we've allocated funds toward trucking capitalization pieces. We're going to add a significant number of them, but we do have long-haul trucking in place so our chemistry reaches the basin, and that would represent a form of capital allocation. This is going to generate considerable savings when it comes to what we pay for logistics. Beyond that, we're still directing some capital expenditure toward JP3, where we're pushing forward on constructing units to keep pace with growth during the latter half of the year — especially for the Data as a Service offering. On top of that, we keep assessing possible chances tied to M&A. My own view is that if you consider how fragmented the chemistry markets are and what's available there, especially when set against what the E&P side looks like on the front end, there could be room to pursue some kind of consolidation play, or alternatively to look at progress and the introduction of new technologies within the JP3 data on excited business. So yes, we remain in the process of weighing those opportunities. When it comes to deploying that money, whatever we fund has to deliver a lot of value back to the company—that's the key consideration.
Don Crist
analystI'd like to inquire regarding that pilot initiative. Clearly, quite some time has passed since it began, and it seems that, that client is fairly happy with how things have gone up to this point; however, have there been any additional sorts of site visits involving different operators who went out, observed the sensor, and sort of witnessed the headway being achieved there? Also, could anything be inferred when comparing other possible deals there against merely this business conducting a trial with?
Ryan Ezell
executiveYeah. So we've experienced a good deal of growth in that area, Don. And I'm not able to just reveal the specific identities from the customer base; however, what I'd share with you is we've witnessed growth in monitoring field gas, we've witnessed a rise in the count of clients examining flares in real time. We've likewise witnessed an exponential growth in the field trials and process foundations we have around on chain of custody measurements and multiple field and geographic locations. So we're genuinely thrilled. We've got in the double-digit number of units deployed in these different areas. Particularly running the Cal-X spectrometer through its paces and making sure that — and typically, we got in line with the former direction unit to make sure everything is lined out run effectively. We're genuinely thrilled about this. And the opportunities continue to come to us, and we're hard at pursuing these.
Don Crist
analystOkay. And when you're getting ready to scale up? I mean, clearly there's a big opportunity ahead of you, I'm assuming all goes according to plan. But looking ahead, are there any major CapEx needs or anything required to construct the greater quantity of sensors you'd require? Or is that sort of already done?
Ryan Ezell
executiveSo we — right now we're aligned on where we're projecting growth, just in, let's say, 2024, that 50% range. We put capital toward front loading slightly more than $2 million to push forward the build on units. Well, that $2 million stretches further when building the Cal-X units, since their cost base is much lower than the original Varex unit. So that's a real improvement there. And then we're sort of working through the processes at present with the adoptions we anticipate, regarding how much extra capital we'll bring forward during the early parts of 2025, considering the growth there.
Don Crist
analystAlright, though at this stage it isn't material.
Ryan Ezell
executiveNo, I'd say that because we could — as I mentioned, if there's a big reduction in unit cost, say we set it at $2.5 million, we're able to add a fair number of units from now until the year is over.
J. Clement
executiveRight. Don, as you recall, the key point regarding the shift to this newer analyzer generation was that expenses come in at about 50% to 60% lower than the top generation.
Don Crist
analystCorrect. Precisely. And I realize that historically, you've moved these units, but you're attempting to transition toward more of a subscription approach. Has there been any favorable or unfavorable sway or response from clients on either option? In other words, do folks still wish to purchase these? Or would they rather have the subscription approach, with you ensuring everything operates correctly moving forward.
Ryan Ezell
executiveThat's an excellent inquiry. I believe as we examine it, it hinges on whether you're dealing with upstream, midstream or downstream use. What I'd regard as the more golden applications are in the midstream segment. Many of the clients whose business we keep growing favor the capital purchase simply due to how the unit gets used. What we're observing is that the majority in the upstream business comes in at 90-plus percent when it comes to either, one, a Data as a Service structure or a hybrid form of service featuring a substantial subscription-based structure with minimal upfront capital outlay for the installation. So I think it somewhat hinges on the use case, but largely the split leans heavily toward subscription based, and upstream, there remains a slight preference for the capital purchase within the midstream portion.
J. Clement
executiveRight. Don, Ryan provided a few figures regarding the share of revenue coming from DaaS as opposed to capital sales, comparing the first quarter with the same period last year. Within those figures, if you isolate DaaS revenue alone on a quarter-over-quarter basis, it rose 30% in Q1 of '24 compared with Q1 of '23. So clearly, folks are shifting toward the DaaS model.
Don Crist
analystGood to hear that. It's far more sustainable and earns a better multiple. Thanks for the detail, everyone. I'll hand it back over.
Eric Swergold
analystCongrats on the impressive progress you've made. A lot of industry articles have been discussing how AI is being used in the E&P sector. Could you explain how your data analytics and chemistry divisions align with this emerging AI framework for E&Ps?
Ryan Ezell
executiveSure; this is genuinely, I'd call it, a thrilling new territory for us, Eric, in that at first, the bulk of our AI-related work centered on our chemometric modeling efforts and what we do on the JP3 side, drawing on that extensive crude sample database we've built up across the past 5 to 7 years. So we're achieving plenty of improvements that speed up model precision, speed up the group fits, especially regarding, I'd say, the chain of custody and rebate for pressure measurement, along with the work we're doing there. And AI remains a major component of that. What's truly been thrilling is that we paused and reflected, saying, look, if you're an innovative chemistry firm holding 200 patents within the advanced reservoir technologies area, considering certain effects at the nanopore scale and what happens with surface interaction, space interactions, and such. We've finished more than 20,000 wells, and we possess production data plus chemistry modeling for all of it; so we've moved in and are now applying AI to genuinely take these data sets, process them, build cubes from various data with that; enhancing how we assess our chemistry's performance so we can make minor formulation tweaks and truly push forward where we'll be down the road and what I regard as better oil recovery across the entire lifespan of the asset. So I believe it's serving a vital role in helping us speed up our technology and the thinking we apply on the chemistry side as well as the data side; and what it's beginning to do is genuinely generate a level of synergy and a distinctive platform, in my view, for Flotek that we'll be discussing a fair amount regarding some of the forthcoming events we have at the Louisiana Energy Conference, and what we'll cover at Intercom and Denver later in August, where we'll be presenting a portion of this work.
B.J. Kirk
analystB.J. Kirk from Singular Research here. You all mentioned external chemistry during this year. My expectation is that it will grow, though I realize volume plays a large role in that. I'm simply wondering whether you folks are planning for, or currently bringing on, additional external operators onto your platform.
Ryan Ezell
executiveAbsolutely, 100%. The main thing we focus on regarding external chemistry is that we have — we've observed the tenure in this position, and our seasonality has moved somewhat. What previously fell in Q3 to Q4 is now, with a bit of <<inaudible>>, the capital discipline in how plans get approached and the capacity to switch Spigit on and off here in the U.S. We've noticed a portion of that seasonality move into Q1, which historically has likely been our slowest quarter for the external chemistry sales piece of it. Yet relative to what I'd say over the tenure of this turnaround we've executed, you've watched the average frac fleet during those quarters decline, while our revenues keep climbing considerably. When you look at, let's say, Q2 through Q4 for the remainder of this year, we have a substantial. We have a genuinely healthy and robust pipeline of ongoing activity with a solid group of what we refer to as our stickier customer base, plus a fair number of new opportunities on the back end here, which is the uptake of our prescriptive chemistry management and our grasp of reservoir technologies rising into prominence. That's as you begin seeing many of these operators shifting toward infield well design and downspacing in how they handle their completions.
Michael Critelli
executiveWe appreciate you being with us once more. At the Louisiana Energy Conference, taking place on May 29, 2024, beginning at 4:00 p.m., Flotek's CEO, Ryan Ezell, is going to take part in a panel focused on the service industry. Our CFO, Bond Clement, will be alongside him to hold meetings with investors, and a copy of the presentation that will be utilized during those investor discussions is going to be posted on the corporate website before the event. We are eager to meet with you. Once more, thank you for being here today. Should you have any further questions, don't hesitate to reach out. Have a wonderful day.
Operator
operatorThis concludes today's conference call. Thank you for your participation. You may now disconnect.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Flotek Industries, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Flotek Industries, Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Flotek Industries, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.